José Luiz Padilha da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
José Luiz Padilha da Silva has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Maria Carmo Pereira Nunes
Programa de Pós-Graduação em Ciências Aplicadas à Saúde do Adulto, Faculdade de Medicina da Universidade Federal de Minas Gerais, Avenida Professor Alfredo Balena, 190, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil
7 shared publications - Antonio Luiz Pinho Ribeiro
Uppsala University
4 shared publications - Ariela Mota Ferreira
Universidade Estadual de Montes Claros, Brasil
3 shared publications - Cesar Augusto Taconeli
Department of Statistics, Federal University of Paraná, Curitiba 81531-980, Brazil
3 shared publications - Ester Cerdeira Sabino
Faculdade de Medicina (FMUSP) and Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil
3 shared publications - Nayara Ragi Baldoni
Universidade de Itaúna, Brazil
3 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (10) , 265
Immune Network Dysregulation Predicts Adverse Outcomes in Infective Endocarditis
Infective endocarditis (IE) is characterized by systemic inflammation, yet the contribution of cytokine network dysregulation to clinical outcomes remains poorly understood. We aimed to evaluate cytokine co-expression patterns in IE and identify immune network signatures associated with in-hospital mortality and major complications. We conducted a prospective cohort study of adult patients hospitalized with IE at a quaternary public hospital in Brazil (2012–2024). Serum cytokines and chemokines were measured at one to three time points during hospitalization. Weighted topological overlap (wTO) and Co-expression Differential Network Analysis (CoDiNA) were used to characterize cytokine interactions in baseline. Logistic mixed-effects models assessed associations between individual cytokines and in-hospital mortality. Of 305 screened patients, 160 met inclusion criteria (41 deaths; in-hospital mortality 25.6%). Survivors exhibited dense, integrated cytokine interaction networks, whereas non-survivors showed markedly fragmented networks with loss of connectivity across multiple cytokines. IFN-γ and IL-1RA formed a preserved but isolated axis in fatal cases, while IL-7 displayed outcome-specific connectivity in patients with infectious complications. A distinct triad involving IFN-γ, IL-1RA, and IL-6 differentiated patients with cardiac complications. In multivariable models adjusted for age, sex, and sampling time, CCL2 was independently associated with in-hospital mortality. Immune network disruption is strongly associated with adverse outcomes in IE. Distinct cytokine signatures, including altered interactions of IFN-γ, IL-1RA, IL-6, IL-7, and CCL2, identify high-risk patients and reveal potential biological pathways underlying clinical deterioration.
- 24 September 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (10) , 265
Open AccessImmune Network Dysregulation Predicts Adverse Outcomes in Infective Endocarditis
Infective endocarditis (IE) is characterized by systemic inflammation, yet the contribution of cytokine network dysregulation to clinical outcomes remains poorly understood. We aimed to evaluate cytokine co-expression patterns in IE and identify immune network signatures associated with in-hospital mortality and major complications. We conducted a prospective cohort study of adult patients hospitalized with IE at a quaternary public hospital in Brazil (2012–2024). Serum cytokines and chemokines were measured at one to three time points during hospitalization. Weighted topological overlap (wTO) and Co-expression Differential Network Analysis (CoDiNA) were used to characterize cytokine interactions in baseline. Logistic mixed-effects models assessed associations between individual cytokines and in-hospital mortality. Of 305 screened patients, 160 met inclusion criteria (41 deaths; in-hospital mortality 25.6%). Survivors exhibited dense, integrated cytokine interaction networks, whereas non-survivors showed markedly fragmented networks with loss of connectivity across multiple cytokines. IFN-γ and IL-1RA formed a preserved but isolated axis in fatal cases, while IL-7 displayed outcome-specific connectivity in patients with infectious complications. A distinct triad involving IFN-γ, IL-1RA, and IL-6 differentiated patients with cardiac complications. In multivariable models adjusted for age, sex, and sampling time, CCL2 was independently associated with in-hospital mortality. Immune network disruption is strongly associated with adverse outcomes in IE. Distinct cytokine signatures, including altered interactions of IFN-γ, IL-1RA, IL-6, IL-7, and CCL2, identify high-risk patients and reveal potential biological pathways underlying clinical deterioration.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 42, e00246125
Association between Chagas disease and the occurrence of stroke: systematic review with meta-analysis
This study aimed to conduct a systematic review of the association between Chagas disease and stroke, and to estimate the magnitude of this association through meta-analyses. A systematic review was conducted following the steps recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The MEDLINE via PubMed, Virtual Health Library, Web of Science, and Embase databases were searched, and all studies on the topic were considered, with no restrictions on language or publication period. Studies lacking the groups of interest (individuals with and without Chagas disease) or stroke as an outcome were excluded. Design-specific meta-analyses were performed using a random-effects model. Of the 1,695 studies identified, 7 were included in the systematic review and 6 in the meta-analysis. Among cohort studies (n = 2), the pooled meta-analysis estimate showed an increased risk of stroke among individuals with Chagas disease (RR = 1.92; 95%CI: 1.20-3.06). Among cross-sectional studies (n = 4), the pooled estimate revealed a higher prevalence of stroke among individuals with Chagas disease (PR = 1.63; 95%CI: 1.22-2.18). The certainty of evidence was rated as very low according to the GRADE approach. The results indicated an association between Chagas disease and stroke; however, they should be interpreted with caution, considering the heterogeneity across study designs and the small number of studies. Further studies with more homogeneous designs are needed to better understand this relationship.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 42, e00246125
Open AccessAssociation between Chagas disease and the occurrence of stroke: systematic review with meta-analysis
This study aimed to conduct a systematic review of the association between Chagas disease and stroke, and to estimate the magnitude of this association through meta-analyses. A systematic review was conducted following the steps recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The MEDLINE via PubMed, Virtual Health Library, Web of Science, and Embase databases were searched, and all studies on the topic were considered, with no restrictions on language or publication period. Studies lacking the groups of interest (individuals with and without Chagas disease) or stroke as an outcome were excluded. Design-specific meta-analyses were performed using a random-effects model. Of the 1,695 studies identified, 7 were included in the systematic review and 6 in the meta-analysis. Among cohort studies (n = 2), the pooled meta-analysis estimate showed an increased risk of stroke among individuals with Chagas disease (RR = 1.92; 95%CI: 1.20-3.06). Among cross-sectional studies (n = 4), the pooled estimate revealed a higher prevalence of stroke among individuals with Chagas disease (PR = 1.63; 95%CI: 1.22-2.18). The certainty of evidence was rated as very low according to the GRADE approach. The results indicated an association between Chagas disease and stroke; however, they should be interpreted with caution, considering the heterogeneity across study designs and the small number of studies. Further studies with more homogeneous designs are needed to better understand this relationship.
- Open Access
- 1 December 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (12)
Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis
- 1 December 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (12)
Open AccessOutcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis
- Open Access
- 22 August 2025
- Published by Revista Brasileira de Biometria in Brazilian Journal of Biometrics
- Vol. 43 (4)
Systematic review and meta-analysis of late diagnosis of Autism Spectrum Disorder (ASD) in women
This article investigates the late diagnosis of Autism Spectrum Disorder (ASD) in women, identifies factors contributing to underdiagnosis and estimates the average age of diagnosis for women diagnosed after the age of 15. Following systematic review and meta-analysis guidelines, the study qualitatively analyzed literature from seven databases and assessed the quality of the studies. A random-effects meta-analysis was used to calculate the average age of diagnosis. Out of 102 studies reviewed, 17 involving 472 women were selected for quantitative analysis. The "Extreme Male Brain," "Female Phenotype," and "Protective Female Effect" theories were identified as factors for underdiagnosis, with an average diagnosis age of 28.24 years and high variability (I² = 99%). The study highlights the need for improved diagnostic strategies and psychological support for women with late ASD diagnosis.
- 22 August 2025
- Published by Revista Brasileira de Biometria in Brazilian Journal of Biometrics
- Vol. 43 (4)
Open AccessSystematic review and meta-analysis of late diagnosis of Autism Spectrum Disorder (ASD) in women
This article investigates the late diagnosis of Autism Spectrum Disorder (ASD) in women, identifies factors contributing to underdiagnosis and estimates the average age of diagnosis for women diagnosed after the age of 15. Following systematic review and meta-analysis guidelines, the study qualitatively analyzed literature from seven databases and assessed the quality of the studies. A random-effects meta-analysis was used to calculate the average age of diagnosis. Out of 102 studies reviewed, 17 involving 472 women were selected for quantitative analysis. The "Extreme Male Brain," "Female Phenotype," and "Protective Female Effect" theories were identified as factors for underdiagnosis, with an average diagnosis age of 28.24 years and high variability (I² = 99%). The study highlights the need for improved diagnostic strategies and psychological support for women with late ASD diagnosis.
- Open Access
- 6 January 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (1) , 65
Quality of Oral Anticoagulation Control with Warfarin According to Sex: A Cross-Sectional Study
Evidence indicates a difference between men and women in oral anticoagulation control, but the results were discrepant. This study investigated the association of sex with oral anticoagulation control in patients on warfarin assisted by anticoagulation clinics (ACs) in Brazil. The cross-sectional study included patients on warfarin recruited at three public ACs in southeast Brazil (2014–2015). The quality of oral anticoagulation was estimated by the time in therapeutic range (TTR). Univariable and multivariable linear regression models were built to examine the association of sociodemographic, behavior, clinical, and drug therapy variables with TTR. Overall, 801 participants were studied (455; 56.8% women), with a mean age of 65.0 (13.4) years. The female sex was associated with lower TTR than the male sex (Beta (95% CI) = −17.01 (−30.25; −3.76), p = 0.012), however, this difference decreased with increasing age, becoming null after age 60. Smoking patients had a lower TTR than non-smokers (−5.18 (−10.02; −0.34), p = 0.036). The results showed that the association of sex with oral anticoagulation control is dependent on age. Women have lower TTR than men, but this difference is null in older patients. Knowledge of these factors may be useful for developing strategies to improve care for these patients.
- 6 January 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (1) , 65
Open AccessQuality of Oral Anticoagulation Control with Warfarin According to Sex: A Cross-Sectional Study
Evidence indicates a difference between men and women in oral anticoagulation control, but the results were discrepant. This study investigated the association of sex with oral anticoagulation control in patients on warfarin assisted by anticoagulation clinics (ACs) in Brazil. The cross-sectional study included patients on warfarin recruited at three public ACs in southeast Brazil (2014–2015). The quality of oral anticoagulation was estimated by the time in therapeutic range (TTR). Univariable and multivariable linear regression models were built to examine the association of sociodemographic, behavior, clinical, and drug therapy variables with TTR. Overall, 801 participants were studied (455; 56.8% women), with a mean age of 65.0 (13.4) years. The female sex was associated with lower TTR than the male sex (Beta (95% CI) = −17.01 (−30.25; −3.76), p = 0.012), however, this difference decreased with increasing age, becoming null after age 60. Smoking patients had a lower TTR than non-smokers (−5.18 (−10.02; −0.34), p = 0.036). The results showed that the association of sex with oral anticoagulation control is dependent on age. Women have lower TTR than men, but this difference is null in older patients. Knowledge of these factors may be useful for developing strategies to improve care for these patients.
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (7) , e20240763
Tendências Temporais na Epidemiologia da Febre Reumática Aguda: Uma Análise Nacional de 2008 a 2022
Resumo Fundamento A febre reumática aguda (FRA) ainda representa um grande desafio de saúde pública, principalmente em países de baixa e média renda. Afeta desproporcionalmente populações não brancas em regiões menos favorecidas e pode evoluir para cardiopatia reumática (CR), associada à alta morbidade e mortalidade. Objetivos Analisar internações e óbitos relacionados à FRA no Brasil entre 2008 e 2022, destacando desigualdades regionais e demográficas. Métodos Estudo transversal baseado em dados de internação e mortalidade por FRA, coletados pelo Sistema de Informações Hospitalares (SIH/SUS). Dados estratificados por características demográficas, região e tipo de visita hospitalar foram analisados utilizando modelos de regressão linear de média móvel para avaliar o impacto de idade, sexo e raça. A significância estatística foi estabelecida em p < 0,05. Resultados Foram registradas 11.061 internações e 65 óbitos por FRA; 53% dos hospitalizados eram homens e 16% eram brancos. A faixa etária de 10 a 14 anos apresentou as maiores taxas de internação, enquanto a de 15 a 19 anos apresentou mais óbitos. As internações foram mais frequentes entre indivíduos não-brancos, concentrando-se no Nordeste do Brasil. Ao longo do tempo, as internações pela FRA diminuíram em todas as demografias, com convergência gradual entre as taxas de homens e mulheres até 2022. Conclusões O estudo revela um declínio nas internações por FRA em todas as regiões e demografias, embora ainda persistam disparidades. Não houve diferença significativa nos casos entre homens e mulheres. Evidência é uma evidência entre fatores socioeconômicos e a carga de doença, afetando mais grupos de baixa renda.
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (7) , e20240763
Open AccessTendências Temporais na Epidemiologia da Febre Reumática Aguda: Uma Análise Nacional de 2008 a 2022
Resumo Fundamento A febre reumática aguda (FRA) ainda representa um grande desafio de saúde pública, principalmente em países de baixa e média renda. Afeta desproporcionalmente populações não brancas em regiões menos favorecidas e pode evoluir para cardiopatia reumática (CR), associada à alta morbidade e mortalidade. Objetivos Analisar internações e óbitos relacionados à FRA no Brasil entre 2008 e 2022, destacando desigualdades regionais e demográficas. Métodos Estudo transversal baseado em dados de internação e mortalidade por FRA, coletados pelo Sistema de Informações Hospitalares (SIH/SUS). Dados estratificados por características demográficas, região e tipo de visita hospitalar foram analisados utilizando modelos de regressão linear de média móvel para avaliar o impacto de idade, sexo e raça. A significância estatística foi estabelecida em p < 0,05. Resultados Foram registradas 11.061 internações e 65 óbitos por FRA; 53% dos hospitalizados eram homens e 16% eram brancos. A faixa etária de 10 a 14 anos apresentou as maiores taxas de internação, enquanto a de 15 a 19 anos apresentou mais óbitos. As internações foram mais frequentes entre indivíduos não-brancos, concentrando-se no Nordeste do Brasil. Ao longo do tempo, as internações pela FRA diminuíram em todas as demografias, com convergência gradual entre as taxas de homens e mulheres até 2022. Conclusões O estudo revela um declínio nas internações por FRA em todas as regiões e demografias, embora ainda persistam disparidades. Não houve diferença significativa nos casos entre homens e mulheres. Evidência é uma evidência entre fatores socioeconômicos e a carga de doença, afetando mais grupos de baixa renda.
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (7)
Temporal Trends in the Epidemiology of Acute Rheumatic Fever: A Nationwide Analysis from 2008 to 2022
Background Acute rheumatic fever (ARF) remains a significant public health challenge, especially in low- and middle-income countries. It disproportionately affects non-white populations in underprivileged regions and may lead to rheumatic heart disease (RHD), which has high morbidity and mortality. Objectives Analyze hospitalizations and deaths related to ARF in Brazil between 2008 and 2022, highlighting regional and demographic inequalities. Methods We conducted a cross-sectional study analyzing hospitalization and mortality data caused by ARF from 2008 to 2022 in Brazil, collected through the Hospital Information System (SIH/SUS). Data were stratified by demographics, region, and hospital visit type (urgent or elective) and analyzed using generalized linear autoregressive moving average models to assess the impact of age, sex, and race. Statistical significance was set at p < 0.05. Results Of 11,061 hospitalizations and 65 deaths from ARF, 53% were male and 16% were white. The 10–14-year-old age group had the highest hospitalization rates, while the 15–19-year-old group had more deaths. Hospitalizations were higher among non-white individuals and concentrated in Brazil’s Northeast. Over time, ARF-related hospitalizations declined across all demographics, with a gradual convergence between male and female rates by 2022. Conclusion Our findings highlight a decline in ARF-related hospitalizations across regions and demographics, though disparities remain. There is no significant difference in ARF cases between men and women. The study highlights a correlation between socioeconomic factors and disease burden, with low-income groups experiencing a higher rate of ARF hospitalizations.
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (7)
Open AccessTemporal Trends in the Epidemiology of Acute Rheumatic Fever: A Nationwide Analysis from 2008 to 2022
Background Acute rheumatic fever (ARF) remains a significant public health challenge, especially in low- and middle-income countries. It disproportionately affects non-white populations in underprivileged regions and may lead to rheumatic heart disease (RHD), which has high morbidity and mortality. Objectives Analyze hospitalizations and deaths related to ARF in Brazil between 2008 and 2022, highlighting regional and demographic inequalities. Methods We conducted a cross-sectional study analyzing hospitalization and mortality data caused by ARF from 2008 to 2022 in Brazil, collected through the Hospital Information System (SIH/SUS). Data were stratified by demographics, region, and hospital visit type (urgent or elective) and analyzed using generalized linear autoregressive moving average models to assess the impact of age, sex, and race. Statistical significance was set at p < 0.05. Results Of 11,061 hospitalizations and 65 deaths from ARF, 53% were male and 16% were white. The 10–14-year-old age group had the highest hospitalization rates, while the 15–19-year-old group had more deaths. Hospitalizations were higher among non-white individuals and concentrated in Brazil’s Northeast. Over time, ARF-related hospitalizations declined across all demographics, with a gradual convergence between male and female rates by 2022. Conclusion Our findings highlight a decline in ARF-related hospitalizations across regions and demographics, though disparities remain. There is no significant difference in ARF cases between men and women. The study highlights a correlation between socioeconomic factors and disease burden, with low-income groups experiencing a higher rate of ARF hospitalizations.
- Open Access
- 10 December 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (s. 3)
Fatores prognósticos associados à sobrevida global e específica em pacientes com câncer de próstata no estado de São Paulo entre 2000 e 2022
Introdução: O câncer de próstata é a segunda neoplasia maligna mais comum entre os homens1 e a segunda principal causa de morte por câncer em homens2,3. Caracteriza-se por uma notável heterogeneidade de variantes histológicas, com distintas características moleculares e patológicas4. Assim, compreender os fatores que influenciam a sobrevida dos pacientes diagnosticados com câncer de próstata é essencial para o manejo do câncer de próstata, contribuindo para a melhoria dos resultados clínicos e da qualidade de vida dos pacientes. Objetivo: Realizar coorte retrospectiva para avaliar a sobrevida global e específica de pacientes com câncer de próstata, do banco de dados da Fundação OncoCentro (São Paulo, Brasil) em um segmento de 22 anos (jan. de 2000 a dez. 2022). Material e Método: Foram elegíveis pacientes registrados com câncer de próstata no banco de dados do OncoCenter (São Paulo, Brasil)5, entre janeiro de 2000 a dezembro de 2022. Curvas de sobrevida pelo método de Kaplan Meier e testes de Log Rank foram elaboradas para investigar o efeito da escolaridade, exames diagnósticos, tipos de tratamentos e outras variáveis sobre a sobrevida global (morte por qualquer causa) e específica (morte por câncer de próstata). Ainda, foram realizadas análises de regressão de Cox tempo dependente, para investigar o efeito das variáveis nos desfechos elencados. Resultados: Um total de 115.956 pacientes foram incluídos no estudo, com uma idade média de 67 anos (variando de 40 a 103 anos). Aproximadamente 15,49% dos pacientes faleceram devido ao câncer depróstata, enquanto 18,50% morreram por outras causas. A média de sobrevida global dos pacientes com câncer de próstata foi de 142 meses (IC 95%, 132-134), enquanto a média de sobrevida específica foi de 70,5 meses (IC 95%, 59,3-60,1). Além disso, foi observado que o aumento da idade e dos níveis de PSA, a diminuição do escore de Gleason e do estágio clínico, bem como a presença de recidiva regional e metástase, influenciaram negativamente a sobrevida global e específica. Enquanto, o manejo dos pacientes com cirurgia e radioterapia demonstraram resultados promissores na maioria dos estágios clínicos. A combinação de cirurgia e radioterapia demonstrou ser a abordagem que proporcionou ganhos significativos na sobrevida global e específica em todos os estágios clínicos. Além disso, verificou-se que um nível educacional mais baixo impactou negativamente nas taxas de sobrevida global e específica dos pacientes. Conclusões: Este estudo revelou que a sobrevida dos pacientes com câncer de próstata é influenciada por fatores como idade, níveis de PSA, escore de Gleason, estágio clínico, recidiva regional, metástase e nível educacional. O tratamento combinado de cirurgia e radioterapia mostrou-se eficaz em melhorar a sobrevida global e específica. Estes achados podem orientar estratégias de tratamento mais eficazes e inclusivas.
- 10 December 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (s. 3)
Open AccessFatores prognósticos associados à sobrevida global e específica em pacientes com câncer de próstata no estado de São Paulo entre 2000 e 2022
Introdução: O câncer de próstata é a segunda neoplasia maligna mais comum entre os homens1 e a segunda principal causa de morte por câncer em homens2,3. Caracteriza-se por uma notável heterogeneidade de variantes histológicas, com distintas características moleculares e patológicas4. Assim, compreender os fatores que influenciam a sobrevida dos pacientes diagnosticados com câncer de próstata é essencial para o manejo do câncer de próstata, contribuindo para a melhoria dos resultados clínicos e da qualidade de vida dos pacientes. Objetivo: Realizar coorte retrospectiva para avaliar a sobrevida global e específica de pacientes com câncer de próstata, do banco de dados da Fundação OncoCentro (São Paulo, Brasil) em um segmento de 22 anos (jan. de 2000 a dez. 2022). Material e Método: Foram elegíveis pacientes registrados com câncer de próstata no banco de dados do OncoCenter (São Paulo, Brasil)5, entre janeiro de 2000 a dezembro de 2022. Curvas de sobrevida pelo método de Kaplan Meier e testes de Log Rank foram elaboradas para investigar o efeito da escolaridade, exames diagnósticos, tipos de tratamentos e outras variáveis sobre a sobrevida global (morte por qualquer causa) e específica (morte por câncer de próstata). Ainda, foram realizadas análises de regressão de Cox tempo dependente, para investigar o efeito das variáveis nos desfechos elencados. Resultados: Um total de 115.956 pacientes foram incluídos no estudo, com uma idade média de 67 anos (variando de 40 a 103 anos). Aproximadamente 15,49% dos pacientes faleceram devido ao câncer depróstata, enquanto 18,50% morreram por outras causas. A média de sobrevida global dos pacientes com câncer de próstata foi de 142 meses (IC 95%, 132-134), enquanto a média de sobrevida específica foi de 70,5 meses (IC 95%, 59,3-60,1). Além disso, foi observado que o aumento da idade e dos níveis de PSA, a diminuição do escore de Gleason e do estágio clínico, bem como a presença de recidiva regional e metástase, influenciaram negativamente a sobrevida global e específica. Enquanto, o manejo dos pacientes com cirurgia e radioterapia demonstraram resultados promissores na maioria dos estágios clínicos. A combinação de cirurgia e radioterapia demonstrou ser a abordagem que proporcionou ganhos significativos na sobrevida global e específica em todos os estágios clínicos. Além disso, verificou-se que um nível educacional mais baixo impactou negativamente nas taxas de sobrevida global e específica dos pacientes. Conclusões: Este estudo revelou que a sobrevida dos pacientes com câncer de próstata é influenciada por fatores como idade, níveis de PSA, escore de Gleason, estágio clínico, recidiva regional, metástase e nível educacional. O tratamento combinado de cirurgia e radioterapia mostrou-se eficaz em melhorar a sobrevida global e específica. Estes achados podem orientar estratégias de tratamento mais eficazes e inclusivas.
- 3 January 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (1) , 10-19
Gastrointestinal Manifestations of Chagas Disease: A Systematic Review with Meta-Analysis
: The aims of this study were to estimate the prevalence of gastrointestinal manifestations among individuals with positive serology for Chagas disease (ChD) and to describe the clinical gastrointestinal manifestations of the disease. A systematic review with meta-analysis was conducted based on the criteria and recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The PubMed, Scopus, Virtual Health Library, Web of Science, and Embase databases were used to search for evidence. Two reviewers independently selected eligible articles and extracted data. RStudio® software was used for the meta-analysis. For subgroup analysis, the studies were divided according to the origin of the individuals included: 1) individuals from health units were included in the health care service prevalence analysis, and 2) individuals from the general population were included in the population prevalence analysis. A total of 2,570 articles were identified, but after removal of duplicates and application of inclusion criteria, 24 articles were included and 21 were part of the meta-analysis. Most of the studies were conducted in Brazil. Radiological diagnosis was the most frequent method used to identify the gastrointestinal clinical form. The combined effect of meta-analysis studies showed a prevalence of gastrointestinal manifestations in individuals with ChD of 12% (95% CI, 8.0–17.0%). In subgroup analysis, the prevalence for studies involving health care services was 16% (95% CI, 11.0–23.0%), while the prevalence for population-based studies was 9% (95% CI, 5.0–15.0%). Megaesophagus and megacolon were the main forms of ChD presentation in the gastrointestinal form. The prevalence of gastrointestinal manifestations of ChD was 12%. Knowing the prevalence of ChD in its gastrointestinal form is an important step in planning health actions for these patients.
- 3 January 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (1) , 10-19
Gastrointestinal Manifestations of Chagas Disease: A Systematic Review with Meta-Analysis
: The aims of this study were to estimate the prevalence of gastrointestinal manifestations among individuals with positive serology for Chagas disease (ChD) and to describe the clinical gastrointestinal manifestations of the disease. A systematic review with meta-analysis was conducted based on the criteria and recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The PubMed, Scopus, Virtual Health Library, Web of Science, and Embase databases were used to search for evidence. Two reviewers independently selected eligible articles and extracted data. RStudio® software was used for the meta-analysis. For subgroup analysis, the studies were divided according to the origin of the individuals included: 1) individuals from health units were included in the health care service prevalence analysis, and 2) individuals from the general population were included in the population prevalence analysis. A total of 2,570 articles were identified, but after removal of duplicates and application of inclusion criteria, 24 articles were included and 21 were part of the meta-analysis. Most of the studies were conducted in Brazil. Radiological diagnosis was the most frequent method used to identify the gastrointestinal clinical form. The combined effect of meta-analysis studies showed a prevalence of gastrointestinal manifestations in individuals with ChD of 12% (95% CI, 8.0–17.0%). In subgroup analysis, the prevalence for studies involving health care services was 16% (95% CI, 11.0–23.0%), while the prevalence for population-based studies was 9% (95% CI, 5.0–15.0%). Megaesophagus and megacolon were the main forms of ChD presentation in the gastrointestinal form. The prevalence of gastrointestinal manifestations of ChD was 12%. Knowing the prevalence of ChD in its gastrointestinal form is an important step in planning health actions for these patients.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação
- Vol. 28
Fatores associados à evasão de calouros no ensino superior: um estudo com dados da Universidade Federal do Recôncavo da Bahia
RESUMO A evasão no ensino superior tem sido objeto de estudo por resultar em desperdícios social, acadêmico e econômico. Neste trabalho, investigamos a evasão de calouros no contexto da Universidade Federal do Recôncavo da Bahia utilizando dados de 19.452 estudantes ingressantes pelo Sistema de Seleção Unificada entre os anos de 2010 e 2019, compreendendo 43 cursos de graduação. Temos como objetivo identificar possíveis associações entre a evasão e os seguintes fatores: sexo, idade de ingresso, admissão por sistema de cotas, cidade de origem e edição do Sistema de Seleção Unificada. Para esse fim, realizamos uma análise descritiva e ajustamos modelos de regressão logística, simples e múltipla, para cada um dos centros de ensino e para os dados agregados. Concluímos que cada centro de ensino apresenta um conjunto distinto de fatores associados à evasão, sendo necessária a adoção de políticas de combate focalizadas nas particularidades identificadas.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação
- Vol. 28
Open AccessFatores associados à evasão de calouros no ensino superior: um estudo com dados da Universidade Federal do Recôncavo da Bahia
RESUMO A evasão no ensino superior tem sido objeto de estudo por resultar em desperdícios social, acadêmico e econômico. Neste trabalho, investigamos a evasão de calouros no contexto da Universidade Federal do Recôncavo da Bahia utilizando dados de 19.452 estudantes ingressantes pelo Sistema de Seleção Unificada entre os anos de 2010 e 2019, compreendendo 43 cursos de graduação. Temos como objetivo identificar possíveis associações entre a evasão e os seguintes fatores: sexo, idade de ingresso, admissão por sistema de cotas, cidade de origem e edição do Sistema de Seleção Unificada. Para esse fim, realizamos uma análise descritiva e ajustamos modelos de regressão logística, simples e múltipla, para cada um dos centros de ensino e para os dados agregados. Concluímos que cada centro de ensino apresenta um conjunto distinto de fatores associados à evasão, sendo necessária a adoção de políticas de combate focalizadas nas particularidades identificadas.